| Vegetable use/week | None 1 - 3 days 4 - 7 days | 0 (0.0) 142 (20.3) 18 (19.8) | 8 (100.0) 558 (79.7) 73 (80.2) | - 1.03 (0.59, 1.78) 1 |
| Vigorous activities/week | None 1 - 4 | 165 (22.1) 2 (2.3) | 582 (77.9) 85 (97.7) | 12.0 (2.93, 48.5) 1 |
| Walking status | None 1 - 3 4 - 7 Daily | 160 (19.7) 4 (40.0) 2 (20.0) 1 (50.0) | 652 (80.3) 6 (60.0) 8 (80.0) 1 (50.0) | 1 2.71 (0.76, 0.97) 1.02 (0.21, 4.84) 4.07 (0.25, 65.5) |
| BMI (kg/m2) | <18 18 - 24 25+ | 8 (4.7) 104 (19.1) 55 (46.2) | 163 (95.3) 440 (80.9) 64 (53.8) | 1 4.82 (2.29, 10.1) 17.5 (7.89, 38.8) |
| Base line HAART usage | Yes No | 57 (20.1) 110 (20.0) | 226 (79.9) 41 (80.0) | 1.01 (0.70, 1.45) 1 |
| Type of drug regimen | No 1a (30) 1a (40) 1b (30) 1b (40) 1c 1e 1f | 57 (20.1) 24 (13.6) 1 (33.3) 29 (22.7) 0 (0.0) 13 (21.7) 14 (18.9) 29 (27.4) | 227 (79.9) 152 (86.4) 2 (66.7) 99 (77.3) 3 (100.0) 47 (78.3) 60 (81.1) 77 (72.6) | 1 0.63 (0.37, 1.06) 1.99 (0.18, 22.4) 1.16 (0.70, 1.93) - 1.10 (0.59, 2.17) 0.93 (0.48, 1.78) 1.50 (0.89, 2.51) |
| Diabetes status | Yes No | 112 (20.7) 2 (11.8) | 428 (79.3) 15 (88.2) | 1.96 (0.42, 8.70) 1 |
| Base line CD4 lymphocyte Count | 500+ 200 - 500 <200 | 53 (19.4) 61 (20.7) 53 (19.9) | 220 (80.6) 233 (79.3) 214 (80.1) | 0.97 (0.64, 1.49) 1.06 (0.70, 1.59) 1 |
| Family History of Diabetes status | No Yes | 149 (19.3) 18 (29.5) | 624 (80.7) 43 (70.5) | 1 1.75 (0.98, 3.13) |
| Family History of hypertension | No Yes | 124 (17.6) 43 (33.3) | 581 (82.4) 86 (66.7) | 1 2.34 (1.55, 3.55) |
| History of UTI | Yes No Unknown | 26 (34.2) 138 (18.3) 3 (100.0) | 50 (65.8) 617 (81.7) 0 (0.0) |
|
| WHO Clinical Stage | Stage I Stage II Stage III Stage IV | 55 (19.0) 18 (19.4) 87 (21.9) 7 (13.2) | 235 (81.0) 75 (80.0) 311 (78.1) 46 (86.8) | 1 1.03 (0.57, 1.85) 1.19 (0.82, 1.74) 0.65 (0.28, 1.52) |
| Base line CD4 lymphocyte Count | 500+ 200 - 500 <200 | 53 (19.4) 61 (20.7) 53 (19.9) | 220 (80.6) 233 (79.3) 214 (80.1) | 1 0.97 (0.64, 1.49) 1.06 (0.70, 1.59) |